| ¿µ¹® | ectopic pregnancy | ÇÑ±Û | ÀÚ±Ã¿Ü ÀӽŠ|
|---|---|---|---|
| ¼³¸í | »êºÎÀΰú ¿µ¿ª¿¡¼ °¡Àå ºó¹øÇÑ ÀÀ±Þ º´À¸·Î, ±× ¹ß»ý ºóµµ´Â ¸Å³â Áõ°¡ÇÏ´Â Ãß¼¼ÀÌ´Ù. ÀÚ±Ã¿Ü ÀÓ½ÅÀº ¼öÁ¤¶õÀÌ Á¤»óÀûÀÎ À§Ä¡ÀÎ ÀڱøöÅëÀÇ ³»°¿¡ Âø»óµÇÁö ¾Ê°í ´Ù¸¥ °÷, Áï ³¼Ò¿¡¼ ³ª¿Â ³ÀÚ¸¦ ÀڱñîÁö ¿î¹ÝÇÏ´Â Àڱðü, ³ÀÚ¸¦ »ý»êÇÏ´Â ³¼Ò, ÀÚ±ÃÀ» ÁöÁöÇÏ´Â ¿©·¯ Àδë, º¹°, ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱðæºÎ µî¿¡ Âø»óµÇ´Â ÀÓ½ÅÀ» ¸»ÇÑ´Ù. Âø»óÇÏ´Â ºÎÀ§¿¡ µû¶ó Àڱðü ÀÓ½Å, Àڱøñ°ü ÀÓ½Å, ³¼Ò ÀÓ½Å, º¹¸·ÀÓ½Å, Àδ볻 ÀӽеîÀ¸·Î ³ª´µ¸ç, °¡Àå ÈçÇÑ ÀÚ±Ã¿Ü ÀÓ½ÅÀº Àڱðü ÀÓ½ÅÀÌ´Ù. ÀÚ±Ã¿Ü ÀÓ½ÅÀÌ Áõ°¡ÇÏ´Â ÀÌÀ¯·Î´Â ¿ì¼± ºÒ°áÇÑ ¼ºÀû Á¢ÃË¿¡ ÀÇÇØ ÀüÆÄµÇ´Â ±Þ¼º ³°ü¿°ÀÇ Áõ°¡¸¦ »ý°¢ÇÒ ¼ö ÀÖ´Ù. ½ÇÁ¦ ±Þ¼º ³°ü¿°À» ¾Î¾Ò´ø ¿©¼ºÀº ±× ´ÙÀ½ Àӽſ¡¼ ÀÚ±Ã¿Ü ÀÓ½ÅÀÌ µÉ È®·üÀÌ Á¤»óÀο¡ ºñÇÏ¿© 7¹è³ª ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¶ÇÇÑ Àڱó» ÇÇÀÓÀåÄ¡¸¦ »ç¿ëÇÏ´Â ¿©¼º¿¡¼µµ Á¤»óÀκ¸´Ù ³ôÀº À²ÀÇ ÀÚ±Ã¿Ü ÀÓ½ÅÀÌ º¸°íµÇ¾ú´Ù. ÀÚ±Ã¿Ü ÀÓ½ÅÀÌ µÇ¸é ¹Ýµå½Ã ´Ù¾çÇÑ ÇüÅÂÀÇ ÇϺ¹ºÎ µ¿ÅëÀ» ³ªÅ¸³½´Ù. ´ëºÎºÐ ÃÖÁ¾ ¿ù°æÀÏÀ» ±âÁØÀ¸·Î 4ÁÖÂë ÈĺÎÅÍ ºÎÁ¤±â ÁúÃâÇ÷À» º¸ÀδÙ. ¶Ç °ú¹Ý¼öÀÇ È¯ÀÚ¿¡¼ À¯¹æÅëÀ̳ª ¸Ö¹Ì µîÀÌ ³ªÅ¸³ª±âµµ Çϳª, ü¿Â »ó½ÂÀº µå¹°´Ù. ±×·¯³ª ºü¸¥¸ÆÀº ÈçÈ÷ º¸ÀÌ´Â Áõ»óÀÌ´Ù. ÀÚ±Ã¿Ü ÀÓ½ÅÀÇ ¹®Á¦Á¡Àº Á¡Á¡ ÀÚ¶õ žƷΠÀÎÇØ¼ ÀÚ±Ã¿Ü ÀÓ½ÅÀÌ µÈ ºÎÀ§(ƯÈ÷ Àڱðü)°¡ ±×°ÍÀÇ Å©±â¸¦ °ßµðÁö ¸øÇؼ ÆÄ¿µÇ´Â °ÍÀÌ´Ù. ±×·¸°Ô µÇ¸é ¸¹Àº ¾çÀÇ Çǰ¡ ÇѲ¨¹ø¿¡ ÃâÇ÷ÀÌ µÇ¾î »ý¸íÀ» ÀÒÀ» ¼öµµ ÀÖ´Ù. ´ëºÎºÐÀÇ ÀÚ±Ã¿Ü ÀÓ½ÅÀº ÇöÀçÀÇ ¹ß´ÞµÈ Áø´Ü¹æ¹ýÀ¸·Î ºü¸£°í Á¤È®ÇÏ°Ô Áø´ÜÇÒ ¼ö ÀÖ´Ù. Áï Á÷Àå°ú ÀڱûçÀÌ¿¡ Á¸ÀçÇÏ´Â º¹°ÀÇ ÀϺκÐÀÎ ¸·ÈùÁÖ¸Ó´Ï(º¹° Áß¿¡¼ °¡Àå ³·Àº ºÎºÐ¿¡ Á¸ÀçÇÏ¿© º¹°³»ÀÇ ÃâÇ÷À̳ª ±âŸÀÇ ¾×ü´Â À̺κп¡ ¸ðÀδÙ)õÀÚ¼ú·Î 0.5mmÀÌ»óÀÇ ºñÀÀÇ÷¼º Ç÷¾×ÀÇ ÈíÀÔÀÌ µÉ °æ¿ì¿¡ ÀÚ±Ã¿Ü ÀÓ½ÅÀÇ ÆÄ¿·Î ÀÎÇÑ ÃâÇ÷ÀÓÀ» ¾Ë ¼ö°¡ ÀÖ°í, ÃÊÀ½ÆÄ ¿µ»ó¹ý¿¡ ÀÇÇÑ Áø´Ü, ÃÖ±ÙÀÇ ¸é¿ª ÈÇÐÀû È£¸£¸ó ÃøÁ¤¹ý°ú º¹°°æ °Ë»ç¹ý, ¶ÇÇÑ Àڱ󻸷 Á¶Á÷°Ë»ç µîÀ¸·Î½á Áø´ÜÇÒ ¼ö ÀÖ´Ù. |
||
| AFP | Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
|---|---|
| grav. | gravida; pregnancy; ÀӽŠ|
| GTN | - Stages of GTN(FIGO, WHO) 1. Stage O; Molar Pregnancy(H-Mole... |
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
| PAPP | Pregnancy Associated Plasma Protein |
| personality tests | Standardised objective tests designed to facilitate the evaluation of personality. (12 Dec 1998) |
|---|---|
| microbial sensitivity tests | Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). (12 Dec 1998) |
| micronucleus tests | Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei in cells which have been exposed to genotoxic agents or ionizing radiation. (12 Dec 1998) |
| clinical chemistry tests | Laboratory tests demonstrating the presence of physiologically significant substances in the blood, urine, tissue, and body fluids with application to the diagnosis or therapy of disease. (12 Dec 1998) |
| placental function tests | Methods used for the assessment of placental function. (12 Dec 1998) |
| complement fixation tests | Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualised by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (haemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. (12 Dec 1998) |
| word association tests | Lists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual. (12 Dec 1998) |
| mutagenicity tests | Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. (12 Dec 1998) |
| haemagglutination inhibition tests | Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of haemagglutination. (12 Dec 1998) |
| haemagglutination tests | Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (12 Dec 1998) |
| haematologic tests | Tests used in the analysis of the hemic system. (12 Dec 1998) |
| precipitin tests | Serologic tests in which a positive reaction manifested by visible precipitation occurs when a soluble antigen reacts with its antibody. (12 Dec 1998) |
| predictive value of tests | In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. (12 Dec 1998) |
| cytotoxicity tests, immunologic | The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitised lymphocyte, an antibody, or complement. (12 Dec 1998) |
| psychological tests | Standardised tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|